Stephen P Squinto's Net Worth

$393 Million

Estimate Recalculated Feb 20, 2024 07:00PM EST

Who is Stephen P Squinto?

Stephen P Squinto has an estimated net worth of $393 Million. This is based on reported shares across multiple companies, which include SpringWorks Therapeutics, Inc., Compass Therapeutics, Inc., Passage BIO, Inc., Chemomab Therapeutics Ltd., Audentes Therapeutics, Inc., and ALEXION PHARMACEUTICALS INC.

SEC CIK

Stephen P Squinto's CIK is 0001231954

Past Insider Trading and Trends

2013 was Stephen P Squinto's most active year for acquiring shares with 16 total transactions. Stephen P Squinto's most active month to acquire stocks was the month of January. 2004 was Stephen P Squinto's most active year for disposing of shares, totalling 47 transactions. Stephen P Squinto's most active month to dispose stocks was the month of April. 2014 saw Stephen P Squinto paying a total of $11,487,388.84 for 111,059 shares, this is the most they've acquired in one year. In 2013 Stephen P Squinto cashed out on 382,152 shares for a total of $28,908,430.61, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SpringWorks Therapeutics, Inc. (SWTX) Snapshot price: $44.99

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.80%
4.82K
131.65K
May 19
Form 4
+0.88%
1.11K
126.83K
May 20
Form 4
-13.39%
-19.43K
$76.19
-$1,480,521.83
125.73K
Scheduled
Apr 27 - Apr 28
Form 4
-1.07%
-1.57K
$75.04
-$117,655.04
145.16K
Scheduled
Apr 14 - Apr 15
Form 4
0
0
May 20
Form 4
0
0
Mar 12
Form 4
7.41M
$18.00
7.41M
Sep 17
Form 4
0
0
Mar 29 - Sep 12
Form 3
0
0
No matching records found

Compass Therapeutics, Inc. (CMPX) Snapshot price: $1.36

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Feb 18
Form 4
0
0
Aug 6
Form 3
0
0
No matching records found

Passage BIO, Inc. (PASG) Snapshot price: $1.02

Head Research and Dev

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Feb 27
Form 3
0
0
No matching records found

Chemomab Therapeutics Ltd. (CMMB) Snapshot price: $0.599399

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Apr 19
Form 3
0
0
No matching records found

Audentes Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Oct 8
Form 4
0
0
Aug 24
Form 3
0
0
No matching records found